The "14th Five-Year Plan" Bio-economic Development Plan to encourage the promotion of international cooperation in the field of health care

Bio-economy is a new economic form based on the development progress and popular application of life science and biotechnology, and is an important part of the national economy. May 10 2022, the National Development and Reform Commission issued the "14th Five-Year" Bio-economy Development Plan (hereinafter referred to as "the Plan"), which clearly establishes the national biotechnology strategic science and technology force and accelerates the breakthrough of bio-economic development bottleneck.

The Plan deploys five key tasks in the development of the bio-economy: firstly, vigorously to consolidate the innovation foundation of the bio-economy. Secondly, to cultivate and strengthen the pillar industries of the bio-economy. Thirdly, to actively promote the protection and utilization of biological resources. Fourthly, to accelerate the construction of biosafety security system. Fifthly, to strive to optimize the policy environment in the biological field.

To comply with the "cure-centered" to "health-centered" new trend. Focus on improving the people's health protection ability, drugs, vaccines, advanced treatment technology and equipment, biomedical materials, precision medicine, testing and biological recreation and other directions, enhance the original innovation capacity, strengthen the scientific research of drug regulation, enhance the supply chain of high-end biomedical products and equipment security level.

Build the highland of bio-economic innovation and development. Guide innovation resources to Beijing, Tianjin, Hebei, Yangtze River Delta, Guangdong, Hong Kong and Macao Bay Area, and cultivate a number of world-class leading enterprises around biomedicine, bio-agriculture, bio-manufacturing and other fields. Capitalize on the advantages of Beijing, Shanghai, Jiangsu, Guangdong, Chengdu-Chongqing twin-city economic circle and other regions with complete bio-industry systems, solid scientific research bases and abundant medical resources to build bio-economic innovation poles and bio-industry innovation highlands with global competitiveness and influence.

To carry out cutting-edge biotechnology innovation. Accelerating the development of high-throughput gene sequencing, and promoting a new generation of sequencing technology innovation marked by single-molecule sequencing. To promote technological innovation in synthetic biology, breakthroughs in computational design, high-throughput screening, efficient expression, precise regulation and other key technologies for biomanufacturing strains. To develop gene therapy, stem cell therapy, immune cell therapy and other new technologies, and strengthen the synergy between industry, academia, research and application. Encouraging the development of bio-computing, deoxyribonucleic acid storage and other new technologies.

Promoting the development of bio-information industry for cardiovascular diseases, tumors, respiratory diseases, diabetes and other major diseases, relying on artificial intelligence technology, biomedical and health data resources, the development of intelligent auxiliary decision-making knowledge models and algorithms to assist personalized new drug development, to provide decision support for disease diagnosis and treatment. Develop remote monitoring equipment, wearable devices and other life support and monitoring products, and develop new nursing and rehabilitation equipment based on intelligent vision and voice interaction, brain-computer interface and other technologies.

Deepening cooperation in bio-economic innovation. Encouraging domestic scientific research institutions in the field of biology to initiate and participate in international scientific programs, and take the initiative to participate in the formulation of international rules and standards in the fields of biological resources protection and utilization, medicine and health, and biopharmaceuticals. Promote innovative drugs, high-end medical devices, genetic testing, pharmaceutical R&D services, Chinese medicine, Internet diagnosis and treatment and other products and services to go abroad, and encourage biological enterprises to accelerate their integration into the international market through the establishment of overseas R&D centers, production bases, sales networks and service systems. Accelerate the construction of foreign cooperation bio-industrial park, to promote international cooperation in the field of health care.

To attract high-quality bio-enterprises to list on the main board and science and technology innovation board. Playing the role of the National Emerging Industry Venture Capital Guidance Fund, Strategic Emerging Industry Fund, etc., and support the development of innovative biotechnology enterprises in accordance with market-oriented principles. Encouraging the gathering of social capital, using angel-round investment, venture capital, and foreign investment power to address the funds required for enterprise R&D and production. To strengthen the cultivation of biological enterprises listed, further increase the support for biological enterprises listed in the domestic capital market, and attract high-quality biological enterprises listed on the main board and science and technology innovation board.